Direct-to-consumer (DTC) marketing has long been a cornerstone of pharma companies’ strategies to connect with patients and promote their products. However, in recent years, a growing number of senior managers in the pharma industry have expressed concerns and have lost confidence in the effectiveness of DTC marketing. This shift in perception is driven by a confluence of factors that challenge the traditional approaches to reaching consumers and building trust. In this blog post, we will explore the reasons behind the erosion of confidence in pharma DTC marketing among senior managers.